nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—PNP—uterus—ovarian cancer	0.0236	0.105	CbGeAlD
Didanosine—PNP—female reproductive system—ovarian cancer	0.0212	0.0939	CbGeAlD
Didanosine—PNP—bone marrow—ovarian cancer	0.02	0.0887	CbGeAlD
Didanosine—PNP—female gonad—ovarian cancer	0.0193	0.0855	CbGeAlD
Didanosine—SLC29A2—female reproductive system—ovarian cancer	0.0159	0.0706	CbGeAlD
Didanosine—PNP—Paclitaxel—Docetaxel—ovarian cancer	0.015	0.608	CbGdCrCtD
Didanosine—SLC29A2—vagina—ovarian cancer	0.0144	0.0638	CbGeAlD
Didanosine—SLC29A1—myometrium—ovarian cancer	0.0135	0.06	CbGeAlD
Didanosine—SLC29A1—uterine cervix—ovarian cancer	0.0105	0.0467	CbGeAlD
Didanosine—SLC29A1—decidua—ovarian cancer	0.01	0.0445	CbGeAlD
Didanosine—SLC29A1—endometrium—ovarian cancer	0.00953	0.0422	CbGeAlD
Didanosine—SLC29A2—lymph node—ovarian cancer	0.00932	0.0413	CbGeAlD
Didanosine—SLC29A1—gonad—ovarian cancer	0.00884	0.0392	CbGeAlD
Didanosine—SLC29A1—uterus—ovarian cancer	0.00878	0.0389	CbGeAlD
Didanosine—SLC29A1—female reproductive system—ovarian cancer	0.0079	0.035	CbGeAlD
Didanosine—SLC29A1—bone marrow—ovarian cancer	0.00745	0.033	CbGeAlD
Didanosine—SLC29A1—female gonad—ovarian cancer	0.00718	0.0318	CbGeAlD
Didanosine—SLC29A1—vagina—ovarian cancer	0.00714	0.0316	CbGeAlD
Didanosine—SLC29A1—testis—ovarian cancer	0.00637	0.0282	CbGeAlD
Didanosine—PNP—Daunorubicin—Epirubicin—ovarian cancer	0.00503	0.204	CbGdCrCtD
Didanosine—PNP—Daunorubicin—Doxorubicin—ovarian cancer	0.00465	0.188	CbGdCrCtD
Didanosine—SLC29A1—lymph node—ovarian cancer	0.00462	0.0205	CbGeAlD
Didanosine—Infection—Topotecan—ovarian cancer	0.00201	0.00268	CcSEcCtD
Didanosine—Pancreatitis—Paclitaxel—ovarian cancer	0.00201	0.00268	CcSEcCtD
Didanosine—Dyspepsia—Chlorambucil—ovarian cancer	0.002	0.00267	CcSEcCtD
Didanosine—Anaphylactic shock—Melphalan—ovarian cancer	0.00198	0.00264	CcSEcCtD
Didanosine—Thrombocytopenia—Topotecan—ovarian cancer	0.00198	0.00264	CcSEcCtD
Didanosine—Decreased appetite—Chlorambucil—ovarian cancer	0.00197	0.00263	CcSEcCtD
Didanosine—Infection—Melphalan—ovarian cancer	0.00197	0.00262	CcSEcCtD
Didanosine—Anaemia—Vinorelbine—ovarian cancer	0.00196	0.00261	CcSEcCtD
Didanosine—Pain—Chlorambucil—ovarian cancer	0.00194	0.00259	CcSEcCtD
Didanosine—Thrombocytopenia—Melphalan—ovarian cancer	0.00194	0.00259	CcSEcCtD
Didanosine—Anorexia—Topotecan—ovarian cancer	0.00193	0.00257	CcSEcCtD
Didanosine—Inflammation—Epirubicin—ovarian cancer	0.00192	0.00256	CcSEcCtD
Didanosine—Malaise—Vinorelbine—ovarian cancer	0.00191	0.00255	CcSEcCtD
Didanosine—Blood uric acid increased—Epirubicin—ovarian cancer	0.0019	0.00253	CcSEcCtD
Didanosine—Leukopenia—Vinorelbine—ovarian cancer	0.0019	0.00253	CcSEcCtD
Didanosine—Anorexia—Melphalan—ovarian cancer	0.00189	0.00252	CcSEcCtD
Didanosine—Hepatocellular injury—Epirubicin—ovarian cancer	0.00186	0.00249	CcSEcCtD
Didanosine—Hyperuricaemia—Doxorubicin—ovarian cancer	0.00186	0.00248	CcSEcCtD
Didanosine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00186	0.00248	CcSEcCtD
Didanosine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00185	0.00246	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00184	0.00246	CcSEcCtD
Didanosine—Abdominal pain upper—Docetaxel—ovarian cancer	0.00183	0.00244	CcSEcCtD
Didanosine—Paraesthesia—Topotecan—ovarian cancer	0.00182	0.00242	CcSEcCtD
Didanosine—Myalgia—Vinorelbine—ovarian cancer	0.0018	0.00241	CcSEcCtD
Didanosine—Arthralgia—Vinorelbine—ovarian cancer	0.0018	0.00241	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.0018	0.00241	CcSEcCtD
Didanosine—Body temperature increased—Chlorambucil—ovarian cancer	0.0018	0.0024	CcSEcCtD
Didanosine—Abdominal pain—Chlorambucil—ovarian cancer	0.0018	0.0024	CcSEcCtD
Didanosine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00179	0.00239	CcSEcCtD
Didanosine—Discomfort—Vinorelbine—ovarian cancer	0.00178	0.00238	CcSEcCtD
Didanosine—Dyspepsia—Topotecan—ovarian cancer	0.00178	0.00237	CcSEcCtD
Didanosine—Inflammation—Doxorubicin—ovarian cancer	0.00178	0.00237	CcSEcCtD
Didanosine—Paraesthesia—Melphalan—ovarian cancer	0.00178	0.00237	CcSEcCtD
Didanosine—Decreased appetite—Topotecan—ovarian cancer	0.00176	0.00235	CcSEcCtD
Didanosine—Blood uric acid increased—Doxorubicin—ovarian cancer	0.00176	0.00234	CcSEcCtD
Didanosine—Neuropathy—Epirubicin—ovarian cancer	0.00175	0.00234	CcSEcCtD
Didanosine—Dyspepsia—Melphalan—ovarian cancer	0.00174	0.00233	CcSEcCtD
Didanosine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00173	0.00231	CcSEcCtD
Didanosine—Pain—Topotecan—ovarian cancer	0.00173	0.00231	CcSEcCtD
Didanosine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00173	0.0023	CcSEcCtD
Didanosine—Hepatocellular injury—Doxorubicin—ovarian cancer	0.00173	0.0023	CcSEcCtD
Didanosine—Dry eye—Epirubicin—ovarian cancer	0.00172	0.0023	CcSEcCtD
Didanosine—Decreased appetite—Melphalan—ovarian cancer	0.00172	0.0023	CcSEcCtD
Didanosine—Infection—Vinorelbine—ovarian cancer	0.00172	0.00229	CcSEcCtD
Didanosine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00169	0.00226	CcSEcCtD
Didanosine—Pain—Melphalan—ovarian cancer	0.00169	0.00226	CcSEcCtD
Didanosine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00167	0.00223	CcSEcCtD
Didanosine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00165	0.00221	CcSEcCtD
Didanosine—Anorexia—Vinorelbine—ovarian cancer	0.00165	0.0022	CcSEcCtD
Didanosine—Asthenia—Chlorambucil—ovarian cancer	0.00163	0.00217	CcSEcCtD
Didanosine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00163	0.00217	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—ovarian cancer	0.00162	0.00216	CcSEcCtD
Didanosine—Pruritus—Chlorambucil—ovarian cancer	0.00161	0.00214	CcSEcCtD
Didanosine—Body temperature increased—Topotecan—ovarian cancer	0.0016	0.00213	CcSEcCtD
Didanosine—Abdominal pain—Topotecan—ovarian cancer	0.0016	0.00213	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—ovarian cancer	0.00159	0.00213	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00158	0.0021	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—ovarian cancer	0.00156	0.00208	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.00156	0.00208	CcSEcCtD
Didanosine—Diarrhoea—Chlorambucil—ovarian cancer	0.00155	0.00207	CcSEcCtD
Didanosine—Paraesthesia—Vinorelbine—ovarian cancer	0.00155	0.00207	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00155	0.00207	CcSEcCtD
Didanosine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00152	0.00202	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—ovarian cancer	0.00151	0.00201	CcSEcCtD
Didanosine—Decreased appetite—Vinorelbine—ovarian cancer	0.0015	0.00201	CcSEcCtD
Didanosine—Hypersensitivity—Topotecan—ovarian cancer	0.00149	0.00199	CcSEcCtD
Didanosine—Pain—Vinorelbine—ovarian cancer	0.00148	0.00197	CcSEcCtD
Didanosine—Chills—Paclitaxel—ovarian cancer	0.00147	0.00196	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—ovarian cancer	0.00147	0.00196	CcSEcCtD
Didanosine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00146	0.00195	CcSEcCtD
Didanosine—Hypersensitivity—Melphalan—ovarian cancer	0.00146	0.00195	CcSEcCtD
Didanosine—Asthenia—Topotecan—ovarian cancer	0.00145	0.00194	CcSEcCtD
Didanosine—Alopecia—Paclitaxel—ovarian cancer	0.00145	0.00193	CcSEcCtD
Didanosine—Vomiting—Chlorambucil—ovarian cancer	0.00144	0.00193	CcSEcCtD
Didanosine—Agranulocytosis—Docetaxel—ovarian cancer	0.00144	0.00193	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00144	0.00192	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—ovarian cancer	0.00144	0.00192	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00143	0.00191	CcSEcCtD
Didanosine—Pruritus—Topotecan—ovarian cancer	0.00143	0.00191	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—ovarian cancer	0.00142	0.0019	CcSEcCtD
Didanosine—Asthenia—Melphalan—ovarian cancer	0.00142	0.0019	CcSEcCtD
Didanosine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00141	0.00189	CcSEcCtD
Didanosine—Flatulence—Paclitaxel—ovarian cancer	0.0014	0.00187	CcSEcCtD
Didanosine—Pruritus—Melphalan—ovarian cancer	0.0014	0.00187	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.0014	0.00187	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—ovarian cancer	0.00139	0.00186	CcSEcCtD
Didanosine—Hepatitis—Docetaxel—ovarian cancer	0.00139	0.00185	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—ovarian cancer	0.00139	0.00185	CcSEcCtD
Didanosine—Diarrhoea—Topotecan—ovarian cancer	0.00138	0.00185	CcSEcCtD
Didanosine—Hypoaesthesia—Docetaxel—ovarian cancer	0.00138	0.00184	CcSEcCtD
Didanosine—Abdominal pain—Vinorelbine—ovarian cancer	0.00137	0.00182	CcSEcCtD
Didanosine—Body temperature increased—Vinorelbine—ovarian cancer	0.00137	0.00182	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—ovarian cancer	0.00136	0.00181	CcSEcCtD
Didanosine—Diarrhoea—Melphalan—ovarian cancer	0.00135	0.00181	CcSEcCtD
Didanosine—Nausea—Chlorambucil—ovarian cancer	0.00135	0.0018	CcSEcCtD
Didanosine—Anaemia—Paclitaxel—ovarian cancer	0.00132	0.00176	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—ovarian cancer	0.00132	0.00176	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00129	0.00173	CcSEcCtD
Didanosine—Vomiting—Topotecan—ovarian cancer	0.00129	0.00172	CcSEcCtD
Didanosine—Malaise—Paclitaxel—ovarian cancer	0.00129	0.00172	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00128	0.00171	CcSEcCtD
Didanosine—Leukopenia—Paclitaxel—ovarian cancer	0.00128	0.0017	CcSEcCtD
Didanosine—Rash—Topotecan—ovarian cancer	0.00128	0.0017	CcSEcCtD
Didanosine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00127	0.0017	CcSEcCtD
Didanosine—Dermatitis—Topotecan—ovarian cancer	0.00127	0.0017	CcSEcCtD
Didanosine—Headache—Topotecan—ovarian cancer	0.00127	0.00169	CcSEcCtD
Didanosine—Vomiting—Melphalan—ovarian cancer	0.00126	0.00168	CcSEcCtD
Didanosine—Rash—Melphalan—ovarian cancer	0.00125	0.00167	CcSEcCtD
Didanosine—Dermatitis—Melphalan—ovarian cancer	0.00125	0.00166	CcSEcCtD
Didanosine—Chills—Docetaxel—ovarian cancer	0.00125	0.00166	CcSEcCtD
Didanosine—Asthenia—Vinorelbine—ovarian cancer	0.00124	0.00166	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00124	0.00165	CcSEcCtD
Didanosine—Alopecia—Docetaxel—ovarian cancer	0.00123	0.00164	CcSEcCtD
Didanosine—Pruritus—Vinorelbine—ovarian cancer	0.00122	0.00163	CcSEcCtD
Didanosine—Arthralgia—Paclitaxel—ovarian cancer	0.00121	0.00162	CcSEcCtD
Didanosine—Myalgia—Paclitaxel—ovarian cancer	0.00121	0.00162	CcSEcCtD
Didanosine—Nausea—Topotecan—ovarian cancer	0.0012	0.0016	CcSEcCtD
Didanosine—Discomfort—Paclitaxel—ovarian cancer	0.0012	0.0016	CcSEcCtD
Didanosine—Dry mouth—Paclitaxel—ovarian cancer	0.00119	0.00158	CcSEcCtD
Didanosine—Diarrhoea—Vinorelbine—ovarian cancer	0.00118	0.00158	CcSEcCtD
Didanosine—Nausea—Melphalan—ovarian cancer	0.00118	0.00157	CcSEcCtD
Didanosine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00116	0.00155	CcSEcCtD
Didanosine—Infection—Paclitaxel—ovarian cancer	0.00116	0.00154	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—ovarian cancer	0.00115	0.00153	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00114	0.00153	CcSEcCtD
Didanosine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00114	0.00152	CcSEcCtD
Didanosine—Anaemia—Docetaxel—ovarian cancer	0.00112	0.00149	CcSEcCtD
Didanosine—Anorexia—Paclitaxel—ovarian cancer	0.00111	0.00148	CcSEcCtD
Didanosine—Vomiting—Vinorelbine—ovarian cancer	0.0011	0.00147	CcSEcCtD
Didanosine—Rash—Vinorelbine—ovarian cancer	0.00109	0.00146	CcSEcCtD
Didanosine—Dermatitis—Vinorelbine—ovarian cancer	0.00109	0.00145	CcSEcCtD
Didanosine—Headache—Vinorelbine—ovarian cancer	0.00108	0.00145	CcSEcCtD
Didanosine—Leukopenia—Docetaxel—ovarian cancer	0.00108	0.00144	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—ovarian cancer	0.00106	0.00142	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00106	0.00141	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—ovarian cancer	0.00106	0.00141	CcSEcCtD
Didanosine—Paraesthesia—Paclitaxel—ovarian cancer	0.00104	0.00139	CcSEcCtD
Didanosine—Myalgia—Docetaxel—ovarian cancer	0.00103	0.00137	CcSEcCtD
Didanosine—Arthralgia—Docetaxel—ovarian cancer	0.00103	0.00137	CcSEcCtD
Didanosine—Nausea—Vinorelbine—ovarian cancer	0.00103	0.00137	CcSEcCtD
Didanosine—Dyspepsia—Paclitaxel—ovarian cancer	0.00102	0.00137	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00102	0.00136	CcSEcCtD
Didanosine—Decreased appetite—Paclitaxel—ovarian cancer	0.00101	0.00135	CcSEcCtD
Didanosine—Dry mouth—Docetaxel—ovarian cancer	0.00101	0.00134	CcSEcCtD
Didanosine—Pain—Paclitaxel—ovarian cancer	0.000995	0.00133	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000986	0.00132	CcSEcCtD
Didanosine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000986	0.00132	CcSEcCtD
Didanosine—Infection—Docetaxel—ovarian cancer	0.00098	0.00131	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000976	0.0013	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—ovarian cancer	0.000973	0.0013	CcSEcCtD
Didanosine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000966	0.00129	CcSEcCtD
Didanosine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000951	0.00127	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000946	0.00126	CcSEcCtD
Didanosine—Anorexia—Docetaxel—ovarian cancer	0.00094	0.00125	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—ovarian cancer	0.000936	0.00125	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000932	0.00124	CcSEcCtD
Didanosine—Body temperature increased—Paclitaxel—ovarian cancer	0.00092	0.00123	CcSEcCtD
Didanosine—Abdominal pain—Paclitaxel—ovarian cancer	0.00092	0.00123	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000913	0.00122	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000901	0.0012	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000899	0.0012	CcSEcCtD
Didanosine—Paraesthesia—Docetaxel—ovarian cancer	0.000886	0.00118	CcSEcCtD
Didanosine—Dyspepsia—Docetaxel—ovarian cancer	0.000868	0.00116	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—ovarian cancer	0.000866	0.00116	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000862	0.00115	CcSEcCtD
Didanosine—Decreased appetite—Docetaxel—ovarian cancer	0.000857	0.00114	CcSEcCtD
Didanosine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000857	0.00114	CcSEcCtD
Didanosine—Pain—Docetaxel—ovarian cancer	0.000843	0.00113	CcSEcCtD
Didanosine—Chills—Epirubicin—ovarian cancer	0.00084	0.00112	CcSEcCtD
Didanosine—Asthenia—Paclitaxel—ovarian cancer	0.000835	0.00111	CcSEcCtD
Didanosine—Alopecia—Epirubicin—ovarian cancer	0.000827	0.0011	CcSEcCtD
Didanosine—Pruritus—Paclitaxel—ovarian cancer	0.000823	0.0011	CcSEcCtD
Didanosine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000806	0.00108	CcSEcCtD
Didanosine—Flatulence—Epirubicin—ovarian cancer	0.000803	0.00107	CcSEcCtD
Didanosine—Diarrhoea—Paclitaxel—ovarian cancer	0.000796	0.00106	CcSEcCtD
Didanosine—Abdominal pain—Docetaxel—ovarian cancer	0.00078	0.00104	CcSEcCtD
Didanosine—Body temperature increased—Docetaxel—ovarian cancer	0.00078	0.00104	CcSEcCtD
Didanosine—Chills—Doxorubicin—ovarian cancer	0.000777	0.00104	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—ovarian cancer	0.000766	0.00102	CcSEcCtD
Didanosine—Anaemia—Epirubicin—ovarian cancer	0.000753	0.00101	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—ovarian cancer	0.000743	0.000991	CcSEcCtD
Didanosine—Vomiting—Paclitaxel—ovarian cancer	0.00074	0.000987	CcSEcCtD
Didanosine—Malaise—Epirubicin—ovarian cancer	0.000735	0.000981	CcSEcCtD
Didanosine—Rash—Paclitaxel—ovarian cancer	0.000734	0.000979	CcSEcCtD
Didanosine—Dermatitis—Paclitaxel—ovarian cancer	0.000733	0.000978	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—ovarian cancer	0.00073	0.000973	CcSEcCtD
Didanosine—Headache—Paclitaxel—ovarian cancer	0.000729	0.000972	CcSEcCtD
Didanosine—Hypersensitivity—Docetaxel—ovarian cancer	0.000727	0.000969	CcSEcCtD
Didanosine—Asthenia—Docetaxel—ovarian cancer	0.000708	0.000944	CcSEcCtD
Didanosine—Pruritus—Docetaxel—ovarian cancer	0.000698	0.000931	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—ovarian cancer	0.000697	0.00093	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—ovarian cancer	0.000694	0.000926	CcSEcCtD
Didanosine—Myalgia—Epirubicin—ovarian cancer	0.000694	0.000926	CcSEcCtD
Didanosine—Nausea—Paclitaxel—ovarian cancer	0.000691	0.000922	CcSEcCtD
Didanosine—Discomfort—Epirubicin—ovarian cancer	0.000686	0.000915	CcSEcCtD
Didanosine—Malaise—Doxorubicin—ovarian cancer	0.00068	0.000907	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—ovarian cancer	0.000679	0.000905	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—ovarian cancer	0.000675	0.000901	CcSEcCtD
Didanosine—Diarrhoea—Docetaxel—ovarian cancer	0.000675	0.0009	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000665	0.000887	CcSEcCtD
Didanosine—Infection—Epirubicin—ovarian cancer	0.000661	0.000882	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000651	0.000869	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—ovarian cancer	0.000642	0.000857	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—ovarian cancer	0.000642	0.000857	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—ovarian cancer	0.000634	0.000846	CcSEcCtD
Didanosine—Anorexia—Epirubicin—ovarian cancer	0.000634	0.000846	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—ovarian cancer	0.000628	0.000838	CcSEcCtD
Didanosine—Vomiting—Docetaxel—ovarian cancer	0.000627	0.000837	CcSEcCtD
Didanosine—Rash—Docetaxel—ovarian cancer	0.000622	0.00083	CcSEcCtD
Didanosine—Dermatitis—Docetaxel—ovarian cancer	0.000621	0.000829	CcSEcCtD
Didanosine—Headache—Docetaxel—ovarian cancer	0.000618	0.000824	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000616	0.000821	CcSEcCtD
Didanosine—Infection—Doxorubicin—ovarian cancer	0.000612	0.000816	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000606	0.000809	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000603	0.000804	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—ovarian cancer	0.000597	0.000797	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—ovarian cancer	0.000587	0.000783	CcSEcCtD
Didanosine—Nausea—Docetaxel—ovarian cancer	0.000586	0.000782	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—ovarian cancer	0.000586	0.000781	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—ovarian cancer	0.000578	0.000771	CcSEcCtD
Didanosine—Pain—Epirubicin—ovarian cancer	0.000569	0.000759	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000561	0.000748	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—ovarian cancer	0.000553	0.000737	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000544	0.000726	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—ovarian cancer	0.000542	0.000723	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—ovarian cancer	0.000535	0.000714	CcSEcCtD
Didanosine—Pain—Doxorubicin—ovarian cancer	0.000526	0.000702	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—ovarian cancer	0.000526	0.000702	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—ovarian cancer	0.000526	0.000702	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000503	0.000671	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—ovarian cancer	0.00049	0.000654	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—ovarian cancer	0.000487	0.000649	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—ovarian cancer	0.000487	0.000649	CcSEcCtD
Didanosine—Asthenia—Epirubicin—ovarian cancer	0.000477	0.000637	CcSEcCtD
Didanosine—Pruritus—Epirubicin—ovarian cancer	0.000471	0.000628	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—ovarian cancer	0.000455	0.000607	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000453	0.000605	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—ovarian cancer	0.000442	0.000589	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—ovarian cancer	0.000435	0.000581	CcSEcCtD
Didanosine—Vomiting—Epirubicin—ovarian cancer	0.000423	0.000564	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—ovarian cancer	0.000421	0.000562	CcSEcCtD
Didanosine—Rash—Epirubicin—ovarian cancer	0.000419	0.00056	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—ovarian cancer	0.000419	0.000559	CcSEcCtD
Didanosine—Headache—Epirubicin—ovarian cancer	0.000417	0.000556	CcSEcCtD
Didanosine—Nausea—Epirubicin—ovarian cancer	0.000395	0.000527	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—ovarian cancer	0.000391	0.000522	CcSEcCtD
Didanosine—Rash—Doxorubicin—ovarian cancer	0.000388	0.000518	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—ovarian cancer	0.000388	0.000517	CcSEcCtD
Didanosine—Headache—Doxorubicin—ovarian cancer	0.000386	0.000514	CcSEcCtD
Didanosine—Nausea—Doxorubicin—ovarian cancer	0.000366	0.000488	CcSEcCtD
